Oakstone The Brigham Board Review in Hematology & Oncology 2016

10 $

+ Include: 56 videos + 2 pdfs, size: 17.3 GB

+ Target Audience: hematology/oncology fellows/trainees, hematologists, oncologists and internists

Description

+ Include: 56 videos + 2 pdfs, size: 17.3 GB

+ Target Audience: hematology/oncology fellows/trainees, hematologists, oncologists and internists

+ Sample video: contact me for sample video

+ Information:

Brigham and Women’s Hospital and Oakstone Board Review

A comprehensive board review designed to update knowledge and improve practice gaps in hematology and oncology based on American Board of Internal Medicine certification requirements. Ideal for MOC.

Stay Current with this CME Board Review in Hematology and Oncology

The Brigham Board Review in Hematology and Oncology is designed to update knowledge and improve practice gaps in hematology and oncology based on American Board of Internal Medicine certification requirements. This case-based board review will help you prep for certification/recertification with an in-depth look at the clinical essentials in both specialties. You’ll learn to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders

Course Directors:
Edwin P. Alyea, III, MD
Associate Professor of Medicine
Harvard Medical School
Associate Director, Bone Marrow/Stem Cell Transplantation Program
Director, Oncology Hospital Medicine
Dana Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Nancy Berliner, MD
Professor of Medicine
Harvard Medical School
Chief, Division of Hematology
Department of Medicine
Brigham and Women’s Hospital

The Brigham Board Review
Distance Learning Series
Ajay K. Singh, MBBS, FRCP (UK), MBA
Senior Associate Dean for Global and Continuing Education
Director, Master in Medical Sciences in Clinical Investigation (MMSCI) Program

Harvard Medical School
Director, Office of Postgraduate Medical Education
Physician, Division of Nephrology, Department of Medicine
Brigham and Women’s Hospital

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Apply current/recommended Hematology and Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders
  • Identify/apply current therapeutic options for for specific Hematologic and Oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology
  • Illustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification Hematology and Oncology examinations

Intended Audience

This course is designed to provide hematology/oncology fellows/trainees, hematologists, oncologists and internists with new knowledge and management strategies to enhance the care of their patients, as well prepare candidates for the ABIM subspecialty board exams in hematology or medical oncology.

Date Of Original Release: June 30, 2016

 

+ Topics:

01. Molecular Genetics of Cancer Levi A. Garraway, MD, PhD.mp4
02. Advances in Cancer Drug Development Geoffrey I. Shapiro, MD, PhD.mp4
03. Infections in Cancer Patients Joel T. Katz, MD.mp4
04. Symptom Management in Patients with Cancer Janet L. Abrahm, MD.mp4
05. Communication- The Key to Excellence in End-of-Life Care Susan D. Block, MD.mp4
06. Biology of Hematopoietic Stem Cell Transplantation Robert J. Soiffer, MD.mp4
07. Biology of Acute Leukemia and Myelodysplastic Syndromes Benjamin L. Ebert, MD, PhD.mp4
08. Acute Leukemias Daniel J. DeAngelo, MD, PhD.mp4
09. Myelodysplastic Syndrome David P. Steensma, MD.mp4
10. Chronic Myelogenous Leukemia Joseph H. Antin. MD.mp4
11. Myeloproliferative Syndromes Ann M. Mullally, MD.mp4
12. Multiple Myeloma Kenneth C. Anderson, MD.mp4
13. Waldenstrom’s Macroglobulemia, Amyloidosis Irene M. Ghobrial, MD.mp4
14. Low Grade Lymphomas Caron A. Jacobson, MD.mp4
15. High Grade Lymphomas Arnold S. Freedman, MD.mp4
16. Hodgkin’s Lymphoma George P. Canellos, MD.mp4
17. Diagnosis and Treatment of CLL and Related B Cell Malignancies Matthew S. Davids, MD.mp4
18. Head and Neck Cancer Robert I. Haddad, MD.mp4
19. Natural History, Screening, Surgery, Small Cell Lung Cancer Bruce E. Johnson, MD.mp4
20. Non Small Cell Lung Cancer Mark Awad, MD.mp4
21. Mesothelioma and Thymoma Geoffrey R. Oxnard, MD.mp4
22. Thyroid Cancer Jochen Lorch, MD.mp4
23. Carcinoid and Pancreatic Neuroendocrine Tumors Matthew H. Kulke, MD.mp4
24. Esophageal and Gastric Cancer Charles S. Fuchs, MD, MPH.mp4
25. Pancreatic and Hepatobilary Cancer Brian M. Wolpin, MD.mp4
26. Anal Cancers Robert J. Mayer, MD.mp4
27. Colorectal Cancers Robert J. Mayer, MD.mp4
28. Gastrointestinal Cancer- Genetic Syndromes Matthew Yurgelun, MD.mp4
29. Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy Christopher J. Sweeney, MBBS.mp4
30. Renal and Bladder Cancer Toni K. Choueiri, MD.mp4
31. Melanoma F. Stephen Hodi, MD.mp4
32. Sarcomas and Gastrointestinal Stromal Tumors (GIST) George D. Demetri, MD.mp4
33. Ovarian Cancer Ursula A. Matulonis, MD.mp4
34. Cervical and Endometrial Cancer Panagiotis A. Konstantinopoulos, MD, PhD .mp4
35. Neuro-oncology David A. Reardon, MD.mp4
36. Breast Cancer- Advances in Staging, Prognosis, Surgery and Radiation, and DCIS Harold J. Burstein, MD, PhD.mp4
37. Breast Cancer- Risk Factors, Genetics, Screening and Prevention Judy E. Garber, MD, MPH.mp4
38. Management for HER2-Positive and Triple Negative Breast Cancer Eric P. Winer, MD.mp4
39. Breast Cancer Survivorship Ann H. Partridae. MD. MPH.mp4
40. Hematopoiesis and Cytokines David T. Scadden, MD.mp4
41. Acquired Bone Marrow Failure Julie A. Losman. MD.mp4
42. Congenital Bone Marrow Failure David A. Williams, MD.mp4
43. Hemophagocytic Syndromes and Related Immunodeficiencies Barbara A. Degar, MD.mp4
44. Anemia- An Overview Ronald P. McCaffrey, MD.mp4
45. Iron Deficiency and Iron Overload Mark D. Fleming, MD, PhD.mp4
46. Immune Hemolytic Anemia Richard M. Kaufman, MD.mp4
47. Non-immune Hemolytic Anemia David E. Golan, PhD, MD.mp4
48. Sickle Cell Disease Maureen M. Okam, MBBS.mp4
49. Thalassemia and other Hemoglobinopathies Matthew M. Heenev. MD.mp4
50. Disorders of Neutrophils Nancy Berliner, MD.mp4
51. Acquired Thrombocytopenias Elisabeth M. Battinelli, MD, PhD.mp4
52. Hemophilia Ellis J. Neufeld, MD, PhD.mp4
53. Von Willebrand Disease and Congenital Platelet Disorders Robert I. Handin, MD.mp4
54. Congenital and Acquired Thrombophilia Kenneth A. Bauer, MD.mp4
55. New Oral Anticoagulants Jean M. Connors, MD.mp4
56. Transfusion Medicine for the Clinician Walter H. Dzik, MD.mp4
Questions.pdf
Syllabus.pdf

Reviews

There are no reviews yet.

Be the first to review “Oakstone The Brigham Board Review in Hematology & Oncology 2016”

Your email address will not be published. Required fields are marked *